{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Others > TasisulamCAS：519055-62-0
Molecular Formula：C11H6BrCl2NO3S2
Molecular Weight：415.11
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：Light yellow to yellow Solid
Qty：
Size：
| CAS | 519055-62-0 |
| Name | Tasisulam |
| Molecular Formula | C11H6BrCl2NO3S2 |
| Molecular Weight | 415.11 |
| Solubility | Soluble in DMSO ≥10mg/mL(Need ultrasonic) |
| Purity | ≥98% |
| Appearance | Light yellow to yellow Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 965-512-7 |
| MDL | MFCD11973637 |
| SMILES | C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br |
| InChIKey | WWONFUQGBVOKOF-UHFFFAOYSA-N |
| InChI | InChI=1S/C11H6BrCl2NO3S2/c12-9-3-4-10(19-9)20(17，18)15-11(16)7-2-1-6(13)5-8(7)14/h1-5H，(H，15，16) |
| PubChem CID | 10160238 |
| Target Point | Others |
| Passage | Others |
| Background | Tasisulam can be used in the study of small molecule anti-tumor drugs to induce cell apoptosis through intrinsic pathway, resulting in cytochrome c release and Caspase-dependent cell death. Tasisulam inhibits the mitotic process and induces vascular normalization. |
| Unit | Bottle |
| Specification | 1mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
